Faced With Adverse Patent Rulings, Pfizer Voices Concern About India’s Deteriorating Business Environment
This article was originally published in PharmAsia News
Executive Summary
After having its patent for Sutent revoked, Pfizer questions India’s commitment to the WTO, saying foreign companies cannot compete fairly in the country.